Evidence map›Paper›PMID 41266369›Full record

ArticleScientific data2025

The ICGC ARGO data dictionary for standardizing global cancer clinical data.

Hardeep K Nahal-Bose, Peter Lichter, Ursula Weber, Lincoln D Stein, Rosita Bajari, Linda Xiang, Edmund Su, Jon Eubank, Ciarán Schütte, Christina K Yung and 1 more

Abstract readDataset
In one paragraph

Article in Scientific data, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hardeep K Nahal-BoseOntario Institute for Cancer Research (OICR), Toronto, ON, M5G 1M1, Canada.ORCID 0000-0002-0774-2862
Peter LichterDivision Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, 69120, Germany.
Ursula WeberDivision Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, 69120, Germany.
Lincoln D SteinOntario Institute for Cancer Research (OICR), Toronto, ON, M5G 1M1, Canada.
Rosita BajariOntario Institute for Cancer Research (OICR), Toronto, ON, M5G 1M1, Canada.
Linda XiangOntario Institute for Cancer Research (OICR), Toronto, ON, M5G 1M1, Canada.
Edmund SuOntario Institute for Cancer Research (OICR), Toronto, ON, M5G 1M1, Canada.
Jon EubankOntario Institute for Cancer Research (OICR), Toronto, ON, M5G 1M1, Canada.
Ciarán SchütteOntario Institute for Cancer Research (OICR), Toronto, ON, M5G 1M1, Canada.
Christina K Yung *Ontario Institute for Cancer Research (OICR), Toronto, ON, M5G 1M1, Canada.
Mélanie Courtot *Ontario Institute for Cancer Research (OICR), Toronto, ON, M5G 1M1, Canada. mcourtot@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The International Cancer Genome Consortium Accelerating Research in Genomic Oncology (ICGC ARGO) project is an international initiative to sequence germline and tumour genomes from 100,000 cancer patients across 13 countries and 22 tumour types. By integrating genomic data with comprehensive clinical information including treatment outcomes, lifestyle, environmental exposures and family history, ICGC ARGO aims to accelerate the application of genomic insights in cancer diagnosis, treatment and prevention. However, a major challenge is harmonizing clinical data from diverse tumour types worldwide. To address this, the ICGC ARGO Data Dictionary was developed to ensure consistent high-quality clinical data collection by defining a minimal set of clinical fields within an event-based data model to capture clinical relationships and support longitudinal data collection. Grounded in international standardized terminology, it is interoperable with other data standards such as Minimal Common Oncology Data Elements (mCODE). Its adoption by global initiatives such as the European-Canadian Cancer Network (EUCANCan) and the Marathon of Hope Cancer Centres Network (MOHCCN) underscores its broad impact on advancing precision oncology research.

Indexed as

GenomicsMedical OncologyNeoplasmsHumans

Identifiers

PMID41266369
PMCPMC12635221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.